Feed: Slashdot
Feed Link: https://slashdot.org/
---

Title: New Antibiotic Could Be a Breakthrough in Treatment for Killer TB,
Trial Suggests

Link: https://science.slashdot.org/story/25/11/19/1...

A new treatment for tuberculosis could boost cure rates and shorten the time
needed to treat the disease by months, trial results suggest. The Guardian:
Globally, an estimated 10.7 million people fell ill with TB last year and
1.23 million died from it. In its annual report on tuberculosis, launched
last week, the World Health Organization said it remained a "major global
public-health problem" and the leading infectious cause of death. [...]
Sorfequiline, a new antibiotic, showed stronger action against the deadly
bacteria than existing treatments, with a comparable safety profile,
researchers from the TB Alliance told the Union Conference on Lung Health in
Copenhagen on Wednesday. The trial involved 309 people across 22 sites in
South Africa, the Philippines, Georgia, Tanzania and Uganda, with different
dose regimens. All participants had "drug-sensitive" tuberculosis, meaning a
standard cocktail of drugs can safely treat them but researchers believe TB
infections that are resistant to standard treatment could also be helped. The
trial suggested a sorfequiline-based regimen could be used for anyone testing
positive, said Dr Maria Beumont, vice-president of TB Alliance.

Read more of this story at Slashdot.

---
VRSS v2.1.180528